According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

University of Connecticut chemists have created two fast, low-cost blood tests that detect microRNA markers linked to ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels in diabetic patients and ...

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor ...

Allen Institute scientists are learning why vaccines can trigger a weaker response in older adults, around age 65, and what ...

Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

Cystic fibrosis (CF) therapeutics refer to treatments designed to manage and alleviate the symptoms of cystic fibrosis, a ...